205 related articles for article (PubMed ID: 10439166)
41. Detection of unknown primary head and neck tumors by positron emission tomography.
Braams JW; Pruim J; Kole AC; Nikkels PG; Vaalburg W; Vermey A; Roodenburg JL
Int J Oral Maxillofac Surg; 1997 Apr; 26(2):112-5. PubMed ID: 9151165
[TBL] [Abstract][Full Text] [Related]
42. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.
Pietsch C; de Galiza Barbosa F; Hüllner MW; Schmid DT; Haerle SK; Huber GF; Studer G; Hany TF; Veit-Haibach P
BMC Med Imaging; 2015 Dec; 15():60. PubMed ID: 26714448
[TBL] [Abstract][Full Text] [Related]
43. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
44. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
[TBL] [Abstract][Full Text] [Related]
45. Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.
Zundel MT; Michel MA; Schultz CJ; Maheshwari M; Wong SJ; Campbell BH; Massey BL; Blumin J; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e825-32. PubMed ID: 21300450
[TBL] [Abstract][Full Text] [Related]
46. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
[TBL] [Abstract][Full Text] [Related]
47. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Oral Oncol; 1999 Jul; 35(4):390-4. PubMed ID: 10645404
[TBL] [Abstract][Full Text] [Related]
48. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
[TBL] [Abstract][Full Text] [Related]
49. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
50. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Myers LL; Wax MK
J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
[TBL] [Abstract][Full Text] [Related]
51. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.
Kostakoglu L; Goldsmith SJ
J Nucl Med; 2004 Jan; 45(1):56-68. PubMed ID: 14734674
[TBL] [Abstract][Full Text] [Related]
52. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Kitagawa Y; Nishizawa S; Sano K; Sadato N; Maruta Y; Ogasawara T; Nakamura M; Yonekura Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Feb; 93(2):202-7. PubMed ID: 11862212
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
Chen B; Zhang H; Liu D; Wang X; Ji B; Gao S
Nucl Med Commun; 2021 May; 42(5):523-527. PubMed ID: 33481505
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of FDG PET in patients with cervical cancer.
Sugawara Y; Eisbruch A; Kosuda S; Recker BE; Kison PV; Wahl RL
J Nucl Med; 1999 Jul; 40(7):1125-31. PubMed ID: 10405131
[TBL] [Abstract][Full Text] [Related]
55. Positron emission tomography in the evaluation of the N0 neck.
Myers LL; Wax MK; Nabi H; Simpson GT; Lamonica D
Laryngoscope; 1998 Feb; 108(2):232-6. PubMed ID: 9473074
[TBL] [Abstract][Full Text] [Related]
56. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
58. Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
Yabuki K; Tsukuda M; Horiuchi C; Taguchi T; Nishimura G
Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1785-92. PubMed ID: 20814690
[TBL] [Abstract][Full Text] [Related]
59. FDG PET in head and neck cancer.
Keyes JW; Watson NE; Williams DW; Greven KM; McGuirt WF
AJR Am J Roentgenol; 1997 Dec; 169(6):1663-9. PubMed ID: 9393187
[TBL] [Abstract][Full Text] [Related]
60. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
Périé S; Talbot JN; Monceaux G; Grahek D; Kerrou K; Montravers F; St Guily JL
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):755-60. PubMed ID: 10961809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
